Guidelines on management of human infection with the novel virus influenza a (H1N1) - A report from the hospital das clínicas of the university of São Paulo

Clinics

Volumn 64, Issue 10, 2009, Pages 1015-1024

  Hajjar, Ludhmila Abrahao ^a   Schout, Denise ^a   Galas, Filomena Regina Barbosa Gomes ^a   Uip, David Everson ^a   Levin, Anna Sara Shafferman ^a   Filho, Helio Hehl Caiaffa ^a   Sakane, Pedro Takanori ^a   Suslik, Carlos Alberto ^a   Teixeira, Jose Manoel de Camargo ^a   Bonfa, Eloisa ^a   Barone, Antonio Alci ^a   Martins, Milton de Arruda ^a   Boulos, Marcos ^a   Auler Jr , Jose Otavio Costa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hospital das Cl cas; Pandemic; Review; Swine Origin Infection Virus

Indexed keywords

EID: 70449560651     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009001000013     Document Type: Review

References (63)

1. Update: swine influenza A (H1N1) infections--California and Texas, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:435-7.
2. Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:585-9.
3. Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400-2.
4. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15.
5. Pandemic (H1N1) 2009 - ECDC Daily Update. 2009. (Accessed August 24, 2009, at http://www.ecdc.europa.eu/en/healthtopics/Documents/090821_Influenza_AH1 N1_Situation_Report_1700hrs.pdf.)
6. Woolhouse ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2005;11:1842-47.
7. Peiris JSM, Poon LLM, Guan Yi. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. Journal of Clinical Virology. 2009;45:169-73.
8. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med. 2009;361(3):225-29.
9. Sandrock C, Kelly T. Clinical review: update of avian influenza A infections in humans. Crit Care. 2007;11:209
10. Kendal AP. Epidemiologic implications of changes in the influenza virus genome. Am J Med. 1987;82:4-14.
11. Brazilian Epidemiologic Report - Influenza A (H1N1). 2009. (Accessed August 24, 2009, at http://portal.saude.gov.br/portal/arquivos/pdf/informe_influenza_se_32_p ublicacao_18ago2009.pdf.)
12. Zimmer SM, Burke DS. Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med 2009;361:279-85.
13. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature. 2008;453:615-19.
14. Garten RJ, Davis CT, Russel CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009; 10;325(5937):197-201.
15. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152-79.
16. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499-522.
17. Heltzer ML, Coffin SE, Maurer K, et al. Immune dysregulation in severe influenza. J Leukoc Biol. 2009;85:1036-43.
18. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962-70.
19. Centers for Disease Control and Prevention. Update: novel influenza A (H1N1) virus infection -Worldwide May 6, 2009. MMWR. 2009;58:453-8.
20. Centers for Disease Control and Prevention. Update: novel influenza A (H1N1) virus infection - Worldwide. MMWR. 2009;58:453-8.
21. Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March--April 2009. MMWR 2009;58:467-70.
22. ECDC working group on influenza A(H1N1)v. Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Eurosurveillance 2009, 14(23). Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19238
23. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-89.
24. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche- Aranda C, Hernandez M, Miller MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674-79.
25. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451-58.
26. Centers for Disease Control and Prevention. Novel influenza A (H1N1) virus infections in three pregnant women-United States, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58: 497-500.
27. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22:164-77.
28. Antonelli M, Conti G, Moro ML, Esquinas A, Gonzalez-Diaz G, Confalonieri M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998; 339:429-35.
29. Ferguson ND, Frutos-Vivar F, Esteban A, Anzueto A, Alía I, Brower RG, et al. Airway pressures, tidal volumes, and mortality in patients with acute respiratory distress syndrome. Crit Care Med. 2005; 33:21-30.
30. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342:1301-08.
31. Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A, for the ARIES Network: A high PEEP-low tidal volume ventilatory strategy improves outcome in persistent ARDS: A randomized controlled trial. Crit Care Med. 2006; 34:1311-18.
32. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med. 1998;338:355-61.
33. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, et al. Lung recruitment in patients with acute respiratory distress syndrome. N Engl J Med. 2006;354:1775-86.
34. Stocker R, Neff T, Stein S, Ecknauer E, Trentz O, Russi E. Prone positioning and low-volume pressure limited ventilation improve survival in patients with severe ARDS. Chest. 1997; 111:1008-17.
35. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med. 2006; 34: 2536-40.
36. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354:2564-75.
37. Russell JA, Walley KR, Singer J, Gordon, AC, Hébert PC, Cooper J, et al. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med. 2008; 358(9):877-87.
38. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Wiebke A, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937-49.
39. Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A, et al. Steroid treatment in ARDS: A critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med. 2008; 34:61-9.
40. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet. 1958;2:1141- 3.
41. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213-65
42. Fahy BG, Sheehy AM and Coursin DB. Glycemic control. Crit Care Med. 2009;37:1769-76.
43. Centers for Disease Control and Prevention. Intensive-Care Patients with severe novel influenza A (H1N1) virus infections - Michigan, June 2009. MMWR 2009;58(27):749-52.
44. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009;45:191-95.
45. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 13;361(7):728-9.
46. Carr MJ, Gunson R, Maclean A, Coughlan S, Fitzgerald M, Scully M, et al. Journal of Clinical Virology. 2009;45:196-99.
47. Chan KH, Lai ST, Poon LL, Guan Y, Yuen KY, Peiris JS. Analytical sensitivity of rapid influenza antigen detection tests for swine-origin influenza virus (H1N1). J Clin Virol. 2009;45:205-7.
48. Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, Ferng YH, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis. 2009;48(9):e88-e92.
49. Centers for Diseases Control. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/h1n1flu/recommendations.htm.
50. Ellis C, McEwen R. Who should receive Tamiflu for swine flu? BMJ. 2009; 6;339:b2698.
51. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009;7;181(1-2):55-8.
52. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301:1034--41.
53. Wallensten A, Oliver I, Lewis D, Harrison S. Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England. Euro Surveill. 2009;14(30):19285.
54. Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, et al. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.Biochem Biophys Res Commun. 2009; 31;385(3):390-4.
55. Couzin-Frankel J. Swine flu outbreak. What role for antiviral drugs? Science. 2009; 8;324(5928):705.
56. Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use.Clin Infect Dis. 2009;48(9):1254-6.
57. CDC. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-- 2010 season. Atlanta, GA: CDC; September 8, 2009. Available at http://www.cdc.gov/h1n1flu/recommendations.htm.
58. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22:164--77.
59. Khazeni N, Bravata DM, Holty JE, Uyeki TM, Stave CD, Gould MK. Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza. Ann Intern Med. 2009 Aug 3. [Epub ahead of print].
60. Robson R, Buttimore A, Lynn K, Brewster M, Ward P. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2006;21(9):2556-62.
61. Lurie N. H1N1 influenza, public health preparedness, and health care reform. N Engl J Med. 2009; 27;361(9):843-5.
62. Azziz-Baumgartner E, Smith N, González-Alvarez R, Daves S, Layton M, Linares N, et al. Influenza Other Respi Viruses. 2009; 3(4):189-96.
63. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine -- Preliminary Report. N Eng J Med. 2009; Published at www.nejm.org September 10, 2009 (10.1056/NEJMoa0907413).